All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Monday on the Main Stage at the ASCRS Annual Meeting featured the Charles D. Kelman, MD, Innovator’s Lecture, by William Link, PhD, and several other presentations on innovations from Sergio Canabrava, MD, Mark Lobanoff, MD, Richard Lewis, MD, Forrest Ellis, MD, and Elizabeth Yeu, MD.
➤ Phase 1/2 trial to evaluate intravitreal implant to delay cataract progression ➤ Update from Phase 1/2 proof-of-concept trial for chronic TED treatment ➤ First patient dosed for investigational, oral geographic atrophy treatment ➤ Pediatric study for pain, inflammation treatment following ocular surgery ➤ Complimentary access to video journal ➤ ASCRS news and events
Following cataract surgery, patients may experience blurry vision. A posterior capsulotomy with the YAG laser is often employed by physicians as a solution to help patients achieve their desired vision. Three physicians shared their experiences and best practices.
➤ Study evaluates safety of office-based lens surgery ➤ FDA issues response to BLA for 8 mg aflibercept ➤ Pre-clinical data for non-viral gene therapy ➤ Non-human primate study of dry AMD therapy ➤ Expanded insurance coverage for MIGS procedures ➤ ASCRS news and events
The purpose of “TOPGUN: Phaco Mavericks,” said David Chang, MD, is to have the world’s top phaco instructors provide their best pearls in cataract surgery. The symposium, which took place at the 2023 ASCRS Annual Meeting, included two teams—ASCRS members and an international team with members from ESCRS, APACRS, and LASCRS.
Immediately sequential bilateral cataract surgery (ISBCS) has been gaining steam, both in discussion and in practice, but as the authors of a recent Journal of Cataract & Refractive Surgery paper point out, it “remains a subject of controversy in ophthalmology.”
➤ Researchers discover new class of drugs that could treat retinal dystrophies ➤ Enrollment complete in Phase 1/2a study using novel dry eye treatment approach ➤ NDA submitted to FDA for investigational inflammation and pain treatment ➤ Study: first-in-human gene therapy trial for achromatopsia ➤ ASCRS news and events
➤ FDA approves ophthalmic spray for mydriasis ➤ FDA accepts NDA for travoprost intraocular implant ➤ FDA accepts supplemental BLA for treatment for macular edema ➤ FDA 510(k) clearance granted to green pattern laser photocoagulator ➤ NDA submitted for pain and inflammation nanoemulsion ➤ Positive clinical results from IOP-monitoring contact lens ➤ Study provides real-world data comparing MIGS using IRIS Registry ➤ FDA approves IOL positioning system ➤ ASCRS news and events
➤ Topline data from Phase 3 presbyopia drop trial ➤ Femtosecond laser for LASIK receives FDA clearance ➤ Enrollment complete for hydrophobic trifocal IOL trial ➤ Early results from clinical trial for dry eye therapy ➤ FDA clears IND application for clinical trial of therapy for X-linked retinoschisis ➤ Innovations in capsulotomy creation device ➤ Company acquisition news ➤ ASCRS news and events
➤ FDA approves new monofocal IOL ➤ Topline Phase 3 results for fixed-dose combination presbyopia drop ➤ Gene therapy trial produces positive Phase 1/2 data for Leber congenital amaurosis ➤ New data shows investigational compound protects endothelium for cataract patients undergoing Fuchs treatment ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.